Rilematovir Uses, Dosage, Side Effects and more
Rilematovir is under investigation in clinical trial NCT04056611 (Effects of JNJ-53718678 in Adult and Adolescent Participants Who Had a Hematopoietic Stem Cell Transplantation and Who Are Infected With Respiratory Syncytial Virus (RSV)).
| Attribute | Details |
|---|---|
| Trade Name | Rilematovir |
| Generic | Rilematovir |
| Rilematovir Other Names | Rilematovir |
| Type | |
| Formula | C21H20ClF3N4O3S |
| Weight | Average: 500.92 Monoisotopic: 500.0896739 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
